SCR7 pyrazine
SIGMA/SML1546 - ≥98% (HPLC)
Synonym: 2,3-
CAS Number: 14892-97-8
Empirical Formula (Hill Notation): C18H12N4OS
Molecular Weight: 332.38
MDL Number: MFCD02167478
Linear Formula: C18H12N4OS
Product Type: Chemical
assay | ≥98% (HPLC) |
color | faintly yellow to dark yellow |
form | powder |
InChI | 1S/C18H12N4OS/c23-17-15-1 |
InChI key | GSRTWXVBHGOUBU-UHFFFAOYSA |
Quality Level | 100 |
SMILES string | O=C(C1=C(N2)N=C(C3=CC=CC= |
solubility | DMSO: 10 mg/mL, clear |
storage temp. | room temp |
Application: | SCR7 pyrazine has been shown to enhance CRISPR genome editing efficiency. To see other small molecule CRISPR enhancers, visit sigma.com/CRISPR-enhancer |
Application: | SCR7 pyrazine has been used as a non-homologous end joining (NHEJ) modulator to study its effect on CRISPR/Cas9-mediated editing. |
Biochem/physiol Actions: | SCR7 pyrazine is reported to be an inhibitor of non-homologous end joining (NHEJ) and has been shown to enhance the efficiency of CRISPR-Cas9 genome editing. The effect of SCR7 pyrazine on the efficiency and targeting precision of CRISPR applications has been shown to be cell type specific and context dependent. SCR7 pyrazine is a product of spontaneous cyclization of SCR7, first reported by Srivastava, M., et al. |
General description: | SCR7 pyrazine is an inhibitor of DNA ligase IV. |
Packaging: | 5, 25 mg in glass bottle |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H302 |
Precautionary statements | P301 + P312 + P330 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥98% (HPLC) |
Storage Temp. | room temp |
UNSPSC | 12352200 |